Biopsy of the red patch at cystoscopy: Is it worthwhile?

European Urology

Volumn 45, Issue 4, 2004, Pages 471-474

  Swinn, M J ^a   Walker, M M ^a   Harbin, L J ^a   Adshead, J M ^a   O'N Witherow, R ^a   Vale, J A ^a   Patel, A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Biopsy; Carcinoma in situ; Cystoscopy; Pathology; Red patch

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; CARCINOMA IN SITU; CONTROLLED STUDY; CYSTOSCOPY; FEMALE; FOLLOW UP; HEMATURIA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH CARCINOMA; TRANSITIONAL CELL CARCINOMA; URETHRA DISEASE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA IN SITU; CYSTOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 1642346086     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2003.11.019     Document Type: Article

References (13)

1. Messing MM, Catalona W. Urothelial tumours of the urinary tract. In: Walsh PC, Retik AB, Darracott Vaughan Jr E, Wein AJ, editors. Campbell's Urology. 7th ed. Philadelphia: W.B. Saunders; 1998. p. 2327-410.
2. Zieger K., Wolf H., Olsen P.R., Hojgaard K. Long-term survival of patients with bladder tumours: the significance of risk factors. Br. J. Urol. 82(5):1998;667-672.
3. Thilagarajah R., Vale J.A., Witherow R.O., Walker M.M. A clinicopathological approach to cystitis - recommendations for simplified pathology reporting. Br. J. Urol. 79:1997;567-571.
4. Sanchez-Carbayo M., Urrutia M., Silva J.M., Romani R., De Buitrago J.M., Navajo J.A. Comparative predictive values of urinary cytology, urinary bladder cancer antigen, CYFRA 21-1 and NMP22 for evaluating symptomatic patients at risk for bladder cancer. J. Urol. 165:2001;1462-1467.
5. Taguchi I., Gohji K., Hara I., Gotoh A., Yamada Y., Yamanaka K.et al. Clinical evaluation of random biopsy of urinary bladder in patients with superficial bladder cancer. Int. J. Urol. 5:1998;30-34.
6. Kiemeney L.A., Witjes J.A., Heijbroek R.P., Kooper N.P., Verbeek A.L., Debruyne F.M. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Br. J. Urol. 73:1994;164-171.
7. Van der Meijden A., Oosterlinck W., Brausi M., Kurth K.H., Sylvester R., de Balincourt C. Significance of bladder biopsies in TaT1 bladder tumours: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. Eur. Urol. 35:1999;267-271.
8. Dalbagni G., Rechtschaffen T., Herr H.W. Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to Bacillus Calmette-Guerrin therapy? J. Urol. 162:1999;708-709.
9. Skemp N.M., Fernandes E.T. Routine bladder biopsy after Bacille Calmette-Guerrin treatment: Is it necessary? Urology. 59:2002;224-226.
10. Ooms E.C.M., Blomjous C.E.M., Zwartendijk J., Veldhuizen R.W., Blok A.P.R., Heinhuis R.J.et al. Connective tissue stroma in bladder papillary transitional cell carcinoma, carcinoma in situ and benign cystitis. Histopathology. 10:1986;613-619.
11. Walker L, Liston TGL, Loyd-Davies RW. Does flexible cystoscopy miss more tumours than rod-lens examination? Br J Urol 1993:449-50.
12. Cina S.J., Epstein J.I., Endrizzi J.M., Harmon W.J., Seay T.M., Schoenberg M.P. Correlation of cystoscopic impression with histological diagnosis of biopsy specimens of the bladder. Human Path. 32:2001;630-637.
13. Kurth K.H., Bouffioux C., Sylvester R., van der Meijden A.P., Oosterlinck W., Brausi M. Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur. Urol. 37(Suppl 3):2000;1-9.